Clearance of Amyloid-Beta in Alzheimer’s Disease: Shifting the Action Site from Center to Periphery-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clearance of Amyloid-Beta in Alzheimer’s Disease: Shifting the Action Site from Center to Periphery

Published:2014-04-15 Issue:1 Volume:51 Page:1-7
ISSN:0893-7648
Container-title:Molecular Neurobiology
language:en
Short-container-title:Mol Neurobiol

Author:

Liu Yu-Hui,Wang Ye-Ran,Xiang Yang,Zhou Hua-Dong,Giunta Brian,Mañucat-Tan Noralyn B.,Tan Jun,Zhou Xin-Fu,Wang Yan-Jiang

Publisher

Springer Science and Business Media LLC

Subject

Neuroscience (miscellaneous),Cellular and Molecular Neuroscience,Neurology

Link

http://link.springer.com/content/pdf/10.1007/s12035-014-8694-9.pdf

Reference60 articles.

1. Dodel R et al (2013) Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer’s disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol 12:233–243. doi: 10.1016/S1474-4422(13)70014-0

2. Doody RS et al (2014) Phase 3 trials of solanezumab for mild-to-moderate Alzheimer’s disease. N Engl J Med 370:311–321. doi: 10.1056/NEJMoa1312889

3. Karran E, Hardy J (2014) Antiamyloid therapy for Alzheimer’s disease—are we on the right road? N Engl J Med 370:377–378. doi: 10.1056/NEJMe1313943

4. Salloway S et al (2014) Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer’s disease. N Engl J Med 370:322–333. doi: 10.1056/NEJMoa1304839

5. Wang YJ (2014) Lessons from immunotherapy for Alzheimer disease. Nat Rev Neurol 10:188–189. doi: 10.1038/nrneurol.2014.44

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-Density Lipoprotein Receptor-Related Protein 1 as a Potential Therapeutic Target in Alzheimer’s Disease;Pharmaceutics;2024-07-17

2. Role of peripheral amyloid-β aggregates in Alzheimer’s disease: mechanistic, diagnostic, and therapeutic implications;Neural Regeneration Research;2024-06-03

3. Understanding the Liver’s Role in the Clearance of Aβ40;Livers;2024-05-23

4. The Basic Requirement of Tight Junction Proteins in Blood-Brain Barrier Function and Their Role in Pathologies;International Journal of Molecular Sciences;2024-05-21

5. Bayesian meta‐analysis of phase 3 results of aducanumab, lecanemab, donanemab, and high‐dose gantenerumab in prodromal and mild Alzheimer's disease;Alzheimer's & Dementia: Translational Research & Clinical Interventions;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3